++
Chapter 34. Schizophrenia Medication Therapy Management Data Set
++
++
++
Which of the following symptoms is included in the diagnostic criteria for schizophrenia?
++
++
++
++
++
++
++
++
++
++
++
++
Which of the following is the most appropriate action for the MTM provider when assessing a patient with schizophrenia?
++
++
++
a. Anticipate cataracts as a common medical complication
++
++
b. Measure cognitive deficits using a brief clinical rating scale
++
++
c. Monitor for tardive dyskinesia only during first-generation antipsychotic treatment
++
++
d. Interpret flat affect, poor speech productivity, and low energy as depression, not negative symptoms
++
++
++
When measuring symptom severity of schizophrenia, which of the following best describes the minimally accepted reduction in total scores that qualifies for a response from antipsychotic treatment?
++
++
++
++
++
++
++
++
++
++
++
++
Using living room language, an MTM provider might describe one of the negative symptoms of schizophrenia as:
++
++
++
++
++
++
++
c. Constant lack of motivation
++
++
d. Always being suspicious of others
++
++
++
A patient with schizophrenia reports that her symptoms have been bothersome for 2 days in a row. Which one of the following should be a part of the medication action plan?
++
++
++
a. Tell the patient to call the psychiatrist and get changed to a new antipsychotic
++
++
b. Instruct the patient to double the dose of antipsychotic for a few days until the symptoms go away
++
++
c. Instruct the patient to disregard the symptoms
++
++
d. Instruct the patient to use coping skills when symptoms occur
++
++
++
All of the following scenarios should result in the MTM provider referring the patient with schizophrenia back to the patient's psychiatrist EXCEPT:
++
++
++
a. When the patient continues to have residual symptoms of schizophrenia over time
++
++
b. When the patient's serum triglycerides continuously increase over time
...